Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,052,127
-$68,517 QoQ
Shares Held
43,693
+9.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#1,301
of 2,821 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SITTNER & NELSON, LLC holds $15,187,262 across 14 Drug Manufacturers - General names. PFE ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,355 | $3,391,769 | |
| 2 | AMGN |
Amgen Inc
|
7,136 | $2,584,088 | |
| 3 | LLY |
ELI LILLY & Co
|
1,120 | $1,343,361 | |
| 4 | NVS |
Novartis AG
|
8,339 | $1,306,888 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
21,398 | $1,232,952 | |
| 6 | PFE |
Pfizer Inc
This page
|
43,693 | $1,052,127 | |
| 7 | MRK |
Merck & Co., Inc.
|
8,165 | $1,049,202 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,100 | $1,023,354 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,052,127 | 43,693 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,120,644 | 39,909 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $971,274 | 39,007 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $967,271 | 37,962 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,084,158 | 44,726 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,162,016 | 45,857 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,141,453 | 43,025 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,572,397 | 54,333 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $1,634,871 | 58,430 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,780,773 | 64,172 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,794,624 | 62,335 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,916,164 | 57,768 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,787,012 | 48,719 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,224,375 | 54,519 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,721,971 | 53,122 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,291,448 | 52,364 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,705,125 | 51,595 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,161,449 | 41,751 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,419,278 | 40,970 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,467,845 | 34,128 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,347,887 | 34,420 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,123,456 | 31,009 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,074,594 | 29,193 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||